Table 2 Characteristics among patients with Antiphospholipid Syndrome

 0–10

3242

16.92

 11–20

1112

5.80

 21–30

1964

10.25

 31–40

2709

14.14

 41–50

2021

10.55

 51–60

2150

11.22

 61–70

2031

10.60

 71–80

2368

12.36

  > 80

1566

8.16

mean ± SD

43.02 ± 26.45

 Female

11,237

58.64

 Male

7926

41.36

 Diabetes mellitus

3548

18.51

 Hypertension

3632

18.95

 Hyperlipidemia

2729

14.24

 Stroke

4006

20.90

 Heart failure

2646

13.81

 Atrial fibrillation

411

2.15

 Myocardial infarction

2197

11.46

 PAOD

1879

9.81

 Chronic kidney disease

3072

16.03

 COPD

3672

19.16

 Deep vein thrombosis

1167

6.09

 Pulmonary embolism

410

2.14

 Systemic lupus erythematosus

419

2.19

 Rheumatoid arthritis

816

4.26

 Systemic sclerosis

53

0.28

 Sjogren’s syndrome

498

2.6

 Polymyositis & dermatomyositis

34

0.18